A Randomized, Double Blind, Placebo-controlled Study to Assess the the Preemptive Benefit of Etoricoxib in Patients Receiving Anterior Cruciate Ligament Reconstruction

NCT00554346 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Post-operational Pain

Interventions

DRUG: Arcoxia(etoricoxib 90 mg/tablet)

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]